AU2003210317A1 - Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564 - Google Patents

Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564

Info

Publication number
AU2003210317A1
AU2003210317A1 AU2003210317A AU2003210317A AU2003210317A1 AU 2003210317 A1 AU2003210317 A1 AU 2003210317A1 AU 2003210317 A AU2003210317 A AU 2003210317A AU 2003210317 A AU2003210317 A AU 2003210317A AU 2003210317 A1 AU2003210317 A1 AU 2003210317A1
Authority
AU
Australia
Prior art keywords
inhibiting
viral
rld
novel compound
serine proteases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210317A
Inventor
Wolf-Georg Forssmann
Frank Kirchhoff
Peter Kreutzmann
Hans-Jurgen Magert
Jan Munch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IPF Pharmaceuticals GmbH
Original Assignee
IPF Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IPF Pharmaceuticals GmbH filed Critical IPF Pharmaceuticals GmbH
Publication of AU2003210317A1 publication Critical patent/AU2003210317A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8135—Kazal type inhibitors, e.g. pancreatic secretory inhibitor, ovomucoid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003210317A 2002-02-22 2003-02-20 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564 Abandoned AU2003210317A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DE10207602 2002-02-22
DE10207602.2 2002-02-22
DE10208302 2002-02-26
DE10208302.9 2002-02-26
DE10209307.5 2002-03-02
DE10209307 2002-03-02
DE10220802.6 2002-05-10
DE10220802 2002-05-10
EP02015418.3 2002-07-11
EP02015418 2002-07-11
PCT/EP2003/001704 WO2003070953A1 (en) 2002-02-22 2003-02-20 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564

Publications (1)

Publication Number Publication Date
AU2003210317A1 true AU2003210317A1 (en) 2003-09-09

Family

ID=27761588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210317A Abandoned AU2003210317A1 (en) 2002-02-22 2003-02-20 Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564

Country Status (3)

Country Link
EP (1) EP1476554A1 (en)
AU (1) AU2003210317A1 (en)
WO (1) WO2003070953A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009010942A1 (en) 2009-02-27 2010-09-02 Universitätsklinikum Schleswig-Holstein Serine protease inhibitors for specific inhibition of tissue kallikreins
EP4126012A1 (en) 2020-03-31 2023-02-08 Pharis Biotec GmbH Polypeptide for the prophylaxis and treatment of viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939851B1 (en) * 1999-06-22 2005-09-06 Pharis Biotec Gmbh Serine proteinase inhibitors
EP1294768A1 (en) * 2000-03-02 2003-03-26 Isis Innovation Limited Mutations in spink5 responsible for netherton's syndrome and atopic diseases
WO2002066513A2 (en) * 2001-02-19 2002-08-29 Ipf Pharmaceuticals Gmbh Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof

Also Published As

Publication number Publication date
WO2003070953A1 (en) 2003-08-28
EP1476554A1 (en) 2004-11-17

Similar Documents

Publication Publication Date Title
AU8875398A (en) 1-amino-7-isoquinoline derivatives as serine protease inhibitors
AU4415899A (en) Alpha-keto oxadiazoles as serine protease inhibitors
AU2002305926A1 (en) Cysteine protease inhibitors
AU2108601A (en) Salicylamides as serine protease inhibitors
AU6007200A (en) Cysteine protease inhibitors
AU2001245764A1 (en) Novel compounds and compositions as protease inhibitors
AU3570000A (en) Substituted azetidin-2-ones as cysteine protease inhibitors
AU2003277891A1 (en) Hcv ns-3 serine protease inhibitors
AU2560700A (en) Acylated aminoacetonitriles as cysteine protease inhibitors
AU4700300A (en) Serine proteases
AU2003247776A1 (en) Serine protease 16
AU1588901A (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors
AU1039801A (en) Compounds and their use as cysteine protease inhibitors
AU2002342682A1 (en) Protease inhibitors
AU2003210317A1 (en) Novel compound for inhibiting serine proteases and for inhibiting viral infections or viral propagation: rld 8564
AU2002348465A1 (en) Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
AU2002302473A1 (en) Detection of inflammations
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
AU2002325108A1 (en) Serine protease inhibitor and processes for the preparation thereof
AU2003292406A1 (en) Serine protease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase